A Study of Tesetaxel Plus Capecitabine in Patients With Solid Tumors
Condition(s):Solid TumorLast Updated:July 24, 2012Unknown status
Hide Studies Not Open or Pending
Condition(s):Solid TumorLast Updated:July 24, 2012Unknown status
Condition(s):Metastatic Triple-Negative Breast CancerLast Updated:January 10, 2022Unknown status
Condition(s):Metastatic Breast Cancer; Recurrent Breast Cancer; Advanced MalignanciesLast Updated:March 12, 2024Recruiting
Condition(s):Advanced Solid TumorsLast Updated:March 8, 2024Recruiting
Condition(s):Unresectable Metastatic Colorectal CancerLast Updated:October 20, 2021Recruiting
Condition(s):Advanced and Metastatic Breast CancerLast Updated:January 10, 2023Completed
Condition(s):Pancreatic CancerLast Updated:August 22, 2023Recruiting
Condition(s):Biliary Tract CancerLast Updated:February 13, 2020Unknown status
Condition(s):Rectal CancerLast Updated:October 24, 2023Recruiting
Condition(s):Relapsed/Refractory Metastatic Pancreatic Ductal AdenocarcinomaLast Updated:February 1, 2019Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.